Jump Financial’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Jump Financial's VKTX Position: Q2 2026 in Review
Jump Financial opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 579,882 shares worth $22.6M. The stake represents 0.18% of the portfolio and ranks #103 among its holdings. This is a return to the name: Jump Financial previously reported a position in VKTX as recently as Q4 2025.
Jump Financial first reported a position in VKTX in Q3 2021 and has held it in 12 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Jump Financial held 579,882 shares of Viking Therapeutics worth $22.6M as of Q2 2026.
- Viking Therapeutics was a new Jump Financial position in Q2 2026.
- Viking Therapeutics made up 0.18% of Jump Financial's portfolio in Q2 2026, its #103 holding.
- Jump Financial first reported a position in Viking Therapeutics in Q3 2021 and has held it in 12 quarters since.
- 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.